PPAR-α agonists (fibrates) are known to induce liver-specific peroxisomal proliferation, hepatomegaly, and ultimately hepatocellular carcinoma in rodents; however, this response is not observed in higher species. This evidence concerns the gene PPARA and hepatocellular carcinoma.